Placental graft trial aims to heal bedsores faster
NCT ID NCT06918548
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a wound covering made from donated human placenta, called NeoThelium FT, helps heal chronic pressure ulcers (bedsores) better than standard care alone. About 148 adults with pressure ulcers on the pelvis or legs will be randomly assigned to receive either the graft plus standard care or standard care only. The main goal is to see if more wounds close completely with the graft.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NeoThelium FT (a dehydrated wound covering made from donated human placental tissue)
What this could lead to
If it works, this could provide a new treatment option to help heal chronic pressure ulcers faster and more completely.
What could go wrong
This is an early-stage trial with no phase designation, so results are uncertain. The treatment may not heal wounds better than standard care alone, and there is a risk of infection or rejection of the graft.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRESSURE INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••